Michael Fridrik
-
- Lymphoma Diagnosis and Treatment 21
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research 16
- Oncology top 5%
- Cancer Treatment and Pharmacology 15
- Colorectal Cancer Treatments and Studies 8
- Cancer Research top 5%
- Breast Cancer Treatment Studies 16
- Hematology top 5%
- Acute Myeloid Leukemia Research 10
- Chronic Myeloid Leukemia Treatments 8
-
- Acute Lymphoblastic Leukemia research 11
- Co-authors
- JR RedmanPeter McLaughlinF SwanSundar JagannathFernando CabanillasP. SalvadorFB HagemeisterRichard Greil
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Michael Fridrik
78 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 83
- Pathology and Forensic Medicine 857
- Genetics 371
- Oncology 898
- Cancer Research 458
- Hematology 247
Countries citing papers authored by Michael Fridrik
This map shows the geographic impact of Michael Fridrik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Fridrik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Fridrik more than expected).
Fields of papers citing papers by Michael Fridrik
This network shows the impact of papers produced by Michael Fridrik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Fridrik. The network helps show where Michael Fridrik may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Fridrik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Torsade de pointes in a patient with severe hypercalcaemia and multiple myeloma. | 2017 | 1 |
| 2 | 2017 | 1 | |
| 3 | 2017 | 8 | |
| 4 | 2017 | 9 | |
| 5 | 2013 | 4 | |
| 6 | 2013 | 1 | |
| 7 | 2011 | 5 | |
| 8 | 2009 | 12 | |
| 9 | 2008 | 24 | |
| 10 | 2005 | 15 | |
| 11 | 2004 | 3 | |
| 12 | 2003 | 52 | |
| 13 | 1999 | 28 | |
| 14 | 1997 | 44 | |
| 15 | 1996 | 9 | |
| 16 | 1995 | 1 | |
| 17 | 1995 | 9 | |
| 18 | 1991 | 1 | |
| 19 | 1989 | 8 | |
| 20 | 1989 | 3 |
About Michael Fridrik
Michael Fridrik is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine, having authored 83 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (21 papers), Chronic Lymphocytic Leukemia Research (16 papers), Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (15 papers), Acute Lymphoblastic Leukemia research (11 papers), Acute Myeloid Leukemia Research (10 papers), Colorectal Cancer Treatments and Studies (8 papers) and Chronic Myeloid Leukemia Treatments (8 papers). The work is most often cited by research in Pathology and Forensic Medicine (857 citations), Genetics (371 citations) and Oncology (898 citations). Michael Fridrik has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include JR Redman, Peter McLaughlin, F Swan, Sundar Jagannath, Fernando Cabanillas, P. Salvador, FB Hagemeister, Richard Greil, H. Hausmaninger and Michael Gnant. Their work appears in journals such as Journal of Clinical Oncology, Blood and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.